Pharmaceutical shortages of various pharmaceutical shortage items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and…
Ended Awarded Last action
- Contract number
- HT001417F0251
- Awardee
-
Broughton Pharmaceuticals, LLC UEI J949HUF889Y1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $500,000
Award facts
- Contract value 100% obligated
- $500,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $500,000 | |
| Original award | $0 |
About this award
This is a firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company. The $500,000.00 contract is for the provision of various pharmaceutical shortage items, including blood products, oncology pharmaceuticals, and other injectable, oral, and inhalation medications. The contract has no set-aside designation and was awarded on August 28, 2017 with a completion date of September 30, 2018. Broughton Pharmaceuticals is an established pharmaceutical wholesaler and specialty distributor that has previously provided a range of medical products and supplies, including shortage pharmaceuticals, to government agencies such as the Department of Veterans Affairs, the Department of Health and Human Services Indian Health Service, and the Defense Health Agency.
Description
Pharmaceutical shortages of various pharmaceutical shortage items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals products including injectables, orals and medicinal inhalations.
Quick answers
Who was awarded contract HT001417F0251?
HT001417F0251 was awarded to Broughton Pharmaceuticals, LLC by Defense Health Agency (Department of Defense) on August 28, 2017.
How much is contract HT001417F0251 worth?
The government has obligated $500,000 on HT001417F0251.
Is contract HT001417F0251 an order under another contract?
Yes. HT001417F0251 is a BPA call under HT001414A0014, a blanket purchase agreement.
Was contract HT001417F0251 competed?
The extent of competition for HT001417F0251 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award